Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 1/2020

07.09.2019 | Image of the Month

18F-FDG PET/CT in lung B lymphoid hyperplasia-type Castleman disease

verfasst von: Paula Fernández-Rodríguez, Rosa Fernández López, Irene Acevedo Báñez, Javier Mohigefer Barrera, José Manuel Jiménez-Hoyuela García

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

We present a 62-year-old woman who, after a catarrhal episode, underwent a chest xray and a chest CT, identifying a pleural-based mass in the left lower lobe. This lesion presented a mixed pattern with solid and peripheral ground-glass attenuation, and an air-bronchogram sign. Despite de suspicion of bronchopneumonia, a lung neoplasm like a predominantly lepidic adenocarcinoma could not be ruled. A 18 F-FDG PET/CT showed a focal radiotracer uptake with SUVmax of 5.34 in the pulmonary lesion, supporting the neoplastic etiology. Consequently, a lower lobectomy was performed and histological examination concluded that the final diagnosis was a B lymphoid hyperplasia-type Castleman disease. Castleman’s disease is an uncommon disorder that can be easily misdiagnosed as lymphoma, neoplasm or infection. Unicentric Castleman’s disease (UCD) usually presents a hyaline-vascular histological subtype and is usually asymptomatic. Extranodal involvement is very rare. Only a few cases of solid organ involvement such us spleen or parotid gland have been described. UCD originating in the lung is extremely rare and should be considered in the differential diagnosis of a primary pulmonary malignant tumor.
Literatur
1.
Zurück zum Zitat Mantas D, Damaskos C, Dailiani P, Samarkos M, Korkolopoulou P. Castleman’s disease of the spleen. Acta Chir Belg. 2017;117:203–8.CrossRef Mantas D, Damaskos C, Dailiani P, Samarkos M, Korkolopoulou P. Castleman’s disease of the spleen. Acta Chir Belg. 2017;117:203–8.CrossRef
2.
Zurück zum Zitat Rawashdeh B, Meyer M, Yimin D, Anthony C, Nguyn D, Moslemi M, et al. Unicentric Castleman’s disease presenting as a pulmonary mass: a diagnostic dilemma. Am J Case Rep. 2015;16:259–61.CrossRef Rawashdeh B, Meyer M, Yimin D, Anthony C, Nguyn D, Moslemi M, et al. Unicentric Castleman’s disease presenting as a pulmonary mass: a diagnostic dilemma. Am J Case Rep. 2015;16:259–61.CrossRef
3.
Zurück zum Zitat Wong RSM. Unicentric Castleman disease. Hematol Oncol Clin North Am. 2018;32:65–73.CrossRef Wong RSM. Unicentric Castleman disease. Hematol Oncol Clin North Am. 2018;32:65–73.CrossRef
4.
Zurück zum Zitat Temirbekov D, Yazici ZM, Ergelen R, Turgut H, Kayhan FT. Castelman disease of the parotid gland: an unusual entity. Otolaryngol Pol. 2014;68:208–11.CrossRef Temirbekov D, Yazici ZM, Ergelen R, Turgut H, Kayhan FT. Castelman disease of the parotid gland: an unusual entity. Otolaryngol Pol. 2014;68:208–11.CrossRef
5.
Zurück zum Zitat Liu Y, Chen G, Qiu X, Xu S, Wu Y, Liu R, et al. Intrapulmonary unicentric Castleman disease mimicking peripheral pulmonary malignancy. Thorac Cancer. 2014;5:576–80.CrossRef Liu Y, Chen G, Qiu X, Xu S, Wu Y, Liu R, et al. Intrapulmonary unicentric Castleman disease mimicking peripheral pulmonary malignancy. Thorac Cancer. 2014;5:576–80.CrossRef
Metadaten
Titel
18F-FDG PET/CT in lung B lymphoid hyperplasia-type Castleman disease
verfasst von
Paula Fernández-Rodríguez
Rosa Fernández López
Irene Acevedo Báñez
Javier Mohigefer Barrera
José Manuel Jiménez-Hoyuela García
Publikationsdatum
07.09.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 1/2020
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-019-04520-3

Weitere Artikel der Ausgabe 1/2020

European Journal of Nuclear Medicine and Molecular Imaging 1/2020 Zur Ausgabe